Which companies overlap with Psoriasis Treatment Center of Central New Jersey's portfolio?

Top competitors by shared drug class: Galderma R&D, Ache Laboratorios Farmaceuticos S.A., Astion Pharma A/S, All India Institute of Medical Sciences, Bhubaneswar, Apotex Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/psoriasis-treatment-center-of-central-new-jersey.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Psoriasis Treatment Center of Central New Jersey — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Psoriasis Treatment Center of Central New Jersey pipeline: 4 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Enstilar 0.005%-0.064% Topical Foam	Enstilar 0.005%-0.064% Topical Foam	marketed	Corticosteroid + Vitamin D analog combination	Glucocorticoid receptor; Vitamin D receptor (VDR)	Dermatology
Topicort Topical Spray	Topicort Topical Spray	marketed	Topical corticosteroid	Glucocorticoid receptor	Dermatology
Ameluz 10% Topical Gel	Ameluz 10% Topical Gel	marketed	Photodynamic therapy agent	Protoporphyrin IX (photosensitizer)	Dermatology/Oncology
Ilumya Injectable Product	Ilumya Injectable Product	marketed	IL-23 inhibitor (monoclonal antibody)	IL-23 p19 subunit	Immunology/Dermatology

Therapeutic area mix

Dermatology · 2
Dermatology/Oncology · 1
Immunology/Dermatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Galderma R&D · 2 shared drug classes
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
Astion Pharma A/S · 1 shared drug class
All India Institute of Medical Sciences, Bhubaneswar · 1 shared drug class
Apotex Inc. · 1 shared drug class
Astellas Pharma Inc · 1 shared drug class
Al-Azhar University · 1 shared drug class
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Psoriasis Treatment Center of Central New Jersey:

Cite this brief

Drug Landscape (2026). Psoriasis Treatment Center of Central New Jersey — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/psoriasis-treatment-center-of-central-new-jersey. Accessed 2026-05-17.